<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03611361</url>
  </required_header>
  <id_info>
    <org_study_id>CP-16-002</org_study_id>
    <nct_id>NCT03611361</nct_id>
  </id_info>
  <brief_title>Wound Imaging Study to Gather Clinical References for a Device to Assist Selecting Level-of-amputation in PAD Patients</brief_title>
  <acronym>WISCR</acronym>
  <official_title>Wound Imaging System to Gather Clinical References: Collection of Clinical References Images for the Second Generation DeepView Wound Imaging System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SpectralMD</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baylor Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>SpectralMD</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a proof-of-concept study to collect images to train a CADe algorithm to predict the&#xD;
      correct level of amputation in individuals scheduled for amputation secondary to PAD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      SpectralMD has developed an imaging device (DeepView), which simultaneously performs&#xD;
      multispectral imaging (MSI) measurements across the visible and infrared spectrum to obtain a&#xD;
      quantitative tissue viability assessment. These optical measurements are integrated using a&#xD;
      CADe algorithm to categorize microvascular blood flow and provide a quantitative assessment&#xD;
      to aid in selecting the appropriate amputation site.&#xD;
&#xD;
      The investigators intend to gather data to train the CADe algorithm to predict ultimate&#xD;
      healing status of tissue in the lower extremities of individuals suffering from peripheral&#xD;
      arterial disease (PAD). The investigators will demonstrate the feasibility of using such an&#xD;
      algorithm to accurately predict the location and extent of small vessel disease prior to&#xD;
      amputation. Eventually, the invesitgators expect the DeepView to reduce the rate of&#xD;
      re-amputation in patients with peripheral arterial disease if used for routine assessment of&#xD;
      patients prior to amputation.&#xD;
&#xD;
      The aims of the study are as follows:&#xD;
&#xD;
        -  Evaluate performance of a Computer Assisted Detection (CADe) algorithm trained to assist&#xD;
           selecting the level-of-amputation in patients with PAD.&#xD;
&#xD;
        -  Identify multispectral signatures that are strongly predictive of viable skin tissue at&#xD;
           proposed amputation sites.&#xD;
&#xD;
        -  Create a representative database for training the CADe algorithm.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 18, 2015</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Standardized amputation healing assessment</measure>
    <time_frame>30-days</time_frame>
    <description>Healing as indicated by: re-epithelialization of tissue within the incision site and no signs of drainage/exudate.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Standardized amputation healing assessment</measure>
    <time_frame>90-days</time_frame>
    <description>Healing as indicated by: re-epithelialization of tissue within the incision site and no signs of drainage/exudate.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Amputation Wound</condition>
  <condition>Peripheral Arterial Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SpectralMD DeepView Wound Imaging System 2.0</intervention_name>
    <description>The DeepView is an imaging device which simultaneously performs multispectral imaging (MSI) measurements across the visible and infrared spectrum to obtain a quantitative tissue viability assessment. These optical measurements are integrated using a machine learning (ML) algorithm to categorize microvascular blood flow and provide a quantitative assessment for selection of tissue healing.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients diagnosed with peripheral arterial disease in a lower extremity.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient must require amputation on a limb secondary to PAD, defined as arterial&#xD;
             insufficiency due to atherosclerosis based on one or more of the following&#xD;
             assessments:&#xD;
&#xD;
               -  Ankle brachial index;&#xD;
&#xD;
               -  Duplex ultrasonography showing clinically significant occlusion;&#xD;
&#xD;
               -  Arteriography; or&#xD;
&#xD;
               -  Assessment demonstrating stenosis by arterial calcification.&#xD;
&#xD;
          -  Able to give informed consent,&#xD;
&#xD;
          -  Be at least 18 years of age.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No history of major amputation on the affected limb, or&#xD;
&#xD;
          -  Life expectancy less than 6 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Dennis Gable, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leah K Gaither</last_name>
    <phone>(972) 499-4934</phone>
    <email>gaither@spectralmd.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dr. Dennis Gable</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucy Miranda</last_name>
      <phone>469-814-4727</phone>
      <email>lucy.miranda@bswhealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kono Y, Muder RR. Identifying the incidence of and risk factors for reamputation among patients who underwent foot amputation. Ann Vasc Surg. 2012 Nov;26(8):1120-6. doi: 10.1016/j.avsg.2012.02.011. Epub 2012 Jul 25.</citation>
    <PMID>22840342</PMID>
  </reference>
  <reference>
    <citation>Zonios G, Bykowski J, Kollias N. Skin melanin, hemoglobin, and light scattering properties can be quantitatively assessed in vivo using diffuse reflectance spectroscopy. J Invest Dermatol. 2001 Dec;117(6):1452-7.</citation>
    <PMID>11886508</PMID>
  </reference>
  <reference>
    <citation>Thatcher JE, Li W, Rodriguez-Vaqueiro Y, Squiers JJ, Mo W, Lu Y, Plant KD, Sellke E, King DR, Fan W, Martinez-Lorenzo JA, DiMaio JM. Multispectral and Photoplethysmography Optical Imaging Techniques Identify Important Tissue Characteristics in an Animal Model of Tangential Burn Excision. J Burn Care Res. 2016 Jan-Feb;37(1):38-52. doi: 10.1097/BCR.0000000000000317.</citation>
    <PMID>26594863</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>July 26, 2018</study_first_submitted>
  <study_first_submitted_qc>July 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2018</study_first_posted>
  <last_update_submitted>October 1, 2019</last_update_submitted>
  <last_update_submitted_qc>October 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>peripheral arterial disease</keyword>
  <keyword>re-amputation</keyword>
  <keyword>optical imaging</keyword>
  <keyword>Computer Assisted Detection (CADe)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

